Dr. Koop reportedly spoke positively about prolotherapy after personally benefiting from the treatment for musculoskeletal pain. His comments have been widely quoted in regenerative medicine literature and prolotherapy educational materials.
One commonly cited quotation attributed to Koop:
The nice thing about prolotherapy, if properly done, is that it cannot do any harm.
Some prolotherapy educational sites note that Koop endorsed the therapy after experiencing clinical benefit himself.
Article references mentioning Koop and prolotherapy
- Reprinted excerpt referencing Koop
- Prolotherapy – Dr. C. Everett Koop’s Story
Contains quoted commentary attributed to Koop regarding prolotherapy’s safety and rationale.
- Historical overview mentioning Koop endorsement
- History of Prolotherapy (Hauser publications context)
Describes the development of prolotherapy literature and references Koop’s association with prolotherapy educational materials.
- Example clinical overview of prolotherapy evidence
- Comprehensive Update of Prolotherapy in the Management of Osteoarthritis
Summarizes modern clinical evidence supporting prolotherapy as a regenerative injection therapy for musculoskeletal pain.
Context
Prolotherapy was originally developed by George S. Hackett in the 1950s as a treatment designed to stimulate ligament and tendon healing through injection of irritant solutions such as hypertonic dextrose.
While prolotherapy has supportive clinical studies for certain conditions (e.g., knee osteoarthritis, tendinopathy), major medical organizations often consider evidence mixed or still evolving, leading to variation in guideline recommendations.